InvestorsHub Logo
Followers 287
Posts 21275
Boards Moderated 4
Alias Born 09/16/2009

Re: ntbiotech post# 31303

Sunday, 09/06/2015 12:41:24 PM

Sunday, September 06, 2015 12:41:24 PM

Post# of 54922
Has nothing to do with COR's "clients", those debt holders were customers of CRGP. They supposedly were debt holders of the shell, their debt was converted to common shares through an exemption that wasnt available. That exemption was applied by CRGP through a fraudulent attorney opinion letter and authorization by the company. It was further pushed through by the TA.

Worse yet the buyback was a direct violation of Rule 10b-18, they held material information form the market. They were buying newly minted shares at discount because of the debt conversions being sold into the market.